What is the IPSS-M for MDS? | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

What is the IPSS-M for MDS?

Webinar: What is IPSS-M for MDS?
Myelodysplastic Syndromes (MDS)
Presentation Date: 
Wed, 05/24/2023 - 12:00pm (EDT)

In this webinar, Dr. Gail Roboz discusses the Molecular International Prognostic Scoring System (IPSS-M) which is a newly developed risk stratification model for myelodysplastic syndromes (MDS) that expands on the original IPSS-R by including data on somatic oncogenic mutations across 31 gene families and weighing their impact on prognosis and outcomes.